IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹119 Cr | ₹93 Cr | ₹70 Cr | ₹56 Cr | ₹42 Cr |
What is the latest Contingent Liabilities ratio of IPCA LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹119 Cr |
Mar2023 | ₹93 Cr |
Mar2022 | ₹70 Cr |
Mar2021 | ₹56 Cr |
Mar2020 | ₹42 Cr |
How is Contingent Liabilities of IPCA LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹119 Cr | 27.48 | |
Mar2023 | ₹93 Cr | 34.12 | |
Mar2022 | ₹70 Cr | 24.95 | |
Mar2021 | ₹56 Cr | 32.51 | |
Mar2020 | ₹42 Cr | - |
Compare Contingent Liabilities of peers of IPCA LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IPCA LABORATORIES | ₹36,602.6 Cr | -6.5% | -11.5% | 40.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,461.0 Cr | 1.4% | -4.1% | 32.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,983.0 Cr | -4.2% | -5.1% | 59.6% | Stock Analytics | |
CIPLA | ₹112,735.0 Cr | -2.2% | -7.3% | 0.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,913.9 Cr | -7.1% | -13.8% | 8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,815.0 Cr | -6.4% | -5.2% | 31.2% | Stock Analytics |
IPCA LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IPCA LABORATORIES | -6.5% |
-11.5% |
40.3% |
SENSEX | -2.2% |
-4% |
5.5% |
You may also like the below Video Courses